Clinical Trial

Micro-nanoplastic Exposure and Coronary Microcirculatory Dysfunction as Well as Cardiovascular Outcomes

Name: Micro-nanoplastic Exposure and Coronary Microcirculatory Dysfunction as Well as Cardiovascular Outcomes — clinical trial record (NCT07748767)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

With strict quality control procedures applied throughout microplastic testing, this study will assess the association between baseline circulating micro-nanoplastic exposure and coronary microvascular dysfunction, as well as subsequent long-term cardiovascular outcomes.

Trial Details

NCT Number	NCT07748767
Lead Sponsor	Beijing Anzhen Hospital
Conditions	Coronary Microvascular Dysfunction (CMD), Microplastic Exposure, Nanoplastics, MACE
Enrollment	184 participants
Start Date	2027-01-01
Primary Completion	2029-12-31 (estimated)
Study Completion	2029-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-06